Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre.Published in:International Journal of Hematology-Oncology & Stem Cell Research, 2018, v. 12, n. 3, p. 196By:Saxena, Mohith;Madabhavi, Irappa;Patel, Apurva;Panchal, Harsha;Anand, AshaPublication type:Article